COVENTRY, 27-Sep-2017 — /EuropaWire/ — The Times/Sunday Times’ Good University Guide 2018 has ranked 22 subjects at the University of Warwick in the UK’s top 10 for their field, including nine in the top 5 – with the Warwick Writing Programme ranked 1st for Creative Writing.
The news follows the Good University Guide naming Warwick 9th in the UK, with the joint 4th highest paid graduates in the UK and the favourite choice of recruiters for companies listed in this year’s list of The Times’ Top 100 Graduate Employers, and the Times Higher Education placing Warwick in the world’s top 100.
Commenting on the subject rankings University of Warwick Pro-Vice Chancellor (Education), Professor Christopher Hughes, said:
“Twenty-two subjects in the UK’s top 10, with nine in the top 5, is a fantastic achievement. The rankings clearly demonstrate the breadth and quality of scholarship, teaching and research excellence that can be found throughout the University of Warwick.”
Commenting previously on Warwick’s being ranked 9th in the UK University of Warwick Vice Chancellor, Professor Stuart Croft, said:
“With our new academic term just days away, I am delighted that the Times and Sunday Times Good University Guide has once again recognised the University of Warwick as one of the UK’s leading universities. This is a testament to the hard work and commitment of Warwick’s students and staff.
“I am also delighted to see that Warwick is the favourite choice of the Times’ top 100 graduate employers, highlighting the outstanding scholarship and dedication of Warwick students.”
The University of Warwick Good University Guide 2018 subject rankings:
SOURCE: University of Warwick
MEDIA CONTACT
Contact:
Tom Frew, Senior Press and Media Relations Manager – University of Warwick:
E: a.t.frew@warwick.ac.uk
M: +44(0)7785433155
(IN BRIEF) Eurex, on April 29, 2024, introduced a new Green Bond Basket within its…
(IN BRIEF) Last Friday, NMB Bank Plc celebrated the listing of its dual-currency sustainability bond,…
(IN BRIEF) CapMan Nordic Infrastructure II fund has reached its final closing at over €375…
(IN BRIEF) AstraZeneca and Daiichi Sankyo's Enhertu, a HER2-directed antibody drug conjugate (ADC), has demonstrated…
(IN BRIEF) AstraZeneca's Truqap, in combination with Faslodex, has received a positive recommendation from the…
(IN BRIEF) Ørsted, a global leader in renewable energy, is divesting its French onshore operations…